Company Breathtec Biomedical Inc Deutsche Boerse AG
Equities
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chris Moreau
CEO | Chief Executive Officer | 59 | 18-02-28 |
James Kinley
DFI | Director of Finance/CFO | 45 | 21-11-30 |
Chief Operating Officer | 41 | 21-02-28 | |
Ahmad Khalil
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Bloomfield
CHM | Chairman | 79 | 21-09-07 |
Chris Moreau
CEO | Chief Executive Officer | 59 | 18-02-28 |
Mark Williams
BRD | Director/Board Member | 52 | 21-09-21 |
James Kinley
DFI | Director of Finance/CFO | 45 | 21-11-30 |
Raj Attariwala
BRD | Director/Board Member | 55 | 15-10-25 |
Howard Gutman
BRD | Director/Board Member | - | 22-02-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,640,762 | 21,285,840 ( 98.36 %) | 0 | 98.36 % |
Company contact information
Algernon Pharmaceuticals, Inc.
601 West Broadway Street Suite 400
V5Z 4C2, Vancouver
+604-398-4175
http://www.algernonpharmaceuticals.comSector
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.21% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |